Octant

Private

Emeryville, CaliforniaHealthcare & Life Scienceshttps://www.octant.bio/

Last Round

Grant

Jun 11, 2025

Total Funding Raised

$124.8M

Company Overview

Octant is a biotechnology company that develops synthetic biology and machine learning platforms to engineer small-molecule therapeutics for complex diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

drug discoverysynthetic biologymultiplexed assaysgenerative biologysmall molecule discoverybiotech platformlead optimizationpolypharmacologyai drug discoverygenerative chemistryhigh-throughput screeningin silico drug discoverydrug-gene-disease mappingtechbiodata as a service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Octant Comparables

Compare Octant with similar companies based on industry and business-model similarity.

Octant comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Octant Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jun 11, 2025
Grant	Apr 1, 2025
Series B	Apr 21, 2022
Series A	May 20, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Sri Kosuri

Co-Founder And CEO

Founding Team

Octant Investors

Notable investors and investment history

Octant investors
Investor	Rounds
Andreessen Horowitz	Series B, Series A
SV Angel	Series A
Allen & Company	Series B, Series A
Gates Family Foundation	Grant
Catalio Capital Management	Series B
Bill & Melinda Gates Foundation	Grant
8VC	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 23, 2025
Launched Latitude, a platform for exploring local experiences.
Apr 4, 2025
Cofounder to speak at RBC 2025 Ophthalmology Conference.

View all signals

Octant Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Octant Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Octant's valuation, stock price, and market status.

Firmographic Details

HeadquartersEmeryville, California

Employee Range68

Year Founded2017

Last FundingJun 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.